Latest news
New release LIPECELTE® trabectedin
Introducing LIPECELTE® Trabectedin: A New Addition to Our Oncology Line At Bioprofarma Bagó, we reaffirm our dedication to patient care with the launch of LIPECELTE® trabectedin, approved by ANMAT...
FUCDIM Uro-Oncology Conference
Bioprofarma Bagó was present on October 24th and 25th at the Uro-Oncology Conference: Controversies and New Developments 2024, organized by the FUCDIM Urology Center in...
New release LIPECELTE® trabectedin
Introducing LIPECELTE® Trabectedin: A New Addition to Our Oncology Line At Bioprofarma Bagó, we reaffirm our dedication to patient care with the launch of LIPECELTE® trabectedin, approved by ANMAT...
FUCDIM Uro-Oncology Conference
Bioprofarma Bagó was present on October 24th and 25th at the Uro-Oncology Conference: Controversies and New Developments 2024, organized by the FUCDIM Urology Center in...
New Product Launch NILTARA®nilotinib
Bioprofarma Bagó is pleased to present the launch of the product NILTARA® nilotinib, for its Hematology Line. This new product has been approved by ANMAT for the...
LACE Congress 2024
The Argentine League Against Epilepsy 2024 Congress took place on September 26th and 27th at the Palais Rouge. For the second consecutive year, Bioprofarma Bagó was...
61st Argentine Congress of Urology
The 61st Argentine Congress of Urology, organized by the Argentine Society of Urology, was held on September 4th, 5th, and 6th at the Sheraton Hotel...
Launch of UroControl®
On Tuesday, September 3rd, we launched a new product, UroControl®, an innovative test for the early detection of relapses in non-muscle-invasive bladder cancer. Bioprofarma Bagó...
New Product Lunch IMPILO®bexarotene
Bioprofarma Bagó is pleased to introduce IMPILO® bexarotene, for its Hematology Line, replacing the historical TARGRETIN® bexarotene. Based on its experience to maintain the same...
26th ARGENTINE CONGRESS OF HEMATOLOGY organized by the Argentine Society of Hematology
Bioprofarma Bagó participated in the 26th Argentine Congress of Hematology 2023, which was held in November 1-4 at its two venues: the Sheraton Hotel and...
XXVI Argentine and International Congress of Clinical Oncology organized by the AAOC
November 8-10, the XXVI Argentine and International Congress of Clinical Oncology 2023 was held at the La Rural property, in the City of Buenos Aires. Under...
New Product Launch VETRANO®palbociclib
We are thrilled to present to our community the launch of the product VETRANO® palbociclib, for our Oncology Line. VETRANO® palbociclib is indicated for...